SHARE:  

February 6, 2023

NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark this link for your convenience.

Subscribe to Weekly Broadcasts

WEEKLY HIGHLIGHT

NRG-GY018 Demonstrates Significantly Improved PFS Outcomes for Women with Advanced or Recurrent Endometrial Cancer with the Addition of Pembrolizumab to Chemotherapy

Read More Here

Thank you for making the NRG Oncology Winter Meeting a success! Recordings are being posted on our website as they become available.


Save the Date for our Summer meeting, July 20-22 in Philadelphia. 

CLOSURES & SUSPENSIONS

GYNECOLOGIC

NRG-GY023: Temporary closure to accrual, effective February 2, 2023, has been put in place, while pre-planned interim analysis proceeds.

 

HEAD & NECK

NRG-HN005: Temporary Closure Notice dated February 3, 2023 (posted on CTSU). The trial is temporarily closed to accrual while pre-planned interim analysis proceeds. 

 

OTHER PROTOCOL NOTICES

1. ALL DISEASE SITES

NRG-GY022: Actively Recruiting MALE Patients only Read More

 

2. CANCER CONTROL & PREVENTION

NRG-CC005/FORTE: February Newsletter (posted on CTSU)

 

3. GASTROINTESTINAL

NRG-GI008/CIRCULATE-US: Natera ctDNA Requisition Forms Quick Reference Guide (posted on CTSU)

 

4. GYNECOLOGIC

Printing Biospecimen Transmittal PDFs on GYN Trials

Please note an effort is underway to clarify how to obtain a Biospecimen Transmittal PDF for submission to the NRG Oncology Biospecimen Bank. Read More

 

GOG-0210: Biospecimens, biomarker data, clinical data, and epidemiologic data are available for request. Please visit the NRG Oncology website for more information on this important study with the overall goal of improving the outcome and/or quality of life for patients with endometrial cancer.

 

NRG-GY012 and NRG-GY023 – BLOOD PRESSURE CUFF SUPPLY IS VERY LIMITED - Please be advised that VWR has a very limited supply of blood pressure cuffs at present. Please check your supplies on site for any overlooked cuffs prior to ordering. Thank you for your cooperation.  

 

NRG-GY018: Dear Patient/Dear Investigator letters, dated February 3, 2023, are now available on CTSU.

 

NRG-GY028: The Biospecimen Collection and Submission Manual and the Assessment Date Calculator can be found on the NRG Oncology website study page (Documents and Materials tab) during the Phase I portion of the study.

 

5. HEAD & NECK

NRG-HN001: The Spanish-translated consent form and CIRB approval of the form are available on CTSU.

 

NRG-HN008

Reminder: please update treatment and AE data weekly. This is a Phase I trial and timely data submission is very important.

 

6. VTOC TRAINING

The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, NRG-CC005, and NRG/SWOG S1914. Space is limited so register now and reserve your seat. The next webinar training is scheduled for Wednesday, February 8, 2023.

DRUG SAFETY UPDATES

Drug Safety updates have been issued for the following studies:

DRUG NAME

PROTOCOL

WEBSITE FOR SAFETY REPORTS

Durvalumab

NRG-GY012

NRG-GY023

NRG-HN004

NRG-LU004

RTOG 1308

CTSU

CTSU

CTSU

NRG

CTSU

Ipilimumab

NRG-BN002

NRG-BN007

NRG-GU012

NRG-HN005

NRG-HN007

NRG-LU002

NRG

CTSU

CTSU

CTSU

CTSU

CTSU

Nivolumab

NRG-BN002

NRG-BN007

NRG-HN005

NRG-HN007

NRG-GU012

NRG-LU002

NRG

CTSU

CTSU

CTSU

CTSU

CTSU

Pembrolizumab

NRG-GY018

NRG-GY020

CTSU

CTSU

NRG-GY018 Press Release

NRG-GY018 demonstrates significantly improved progression-free survival outcomes for women with advanced or recurrent endometrial cancer with the addition of pembrolizumab to chemotherapy. Read the Full Press Release

 

NRG Oncology Study Overview Videos for Investigators

The NRG Oncology Communications Team has been conducting video interviews with study PIs for NRG trials that are currently open to accrual. The video interviews filmed at the Summer 2022 NRG Oncology Meeting in Chicago are currently available for viewing for the following studies: NRG-BN010 (temporarily closed to accrual), NRG-GI005, NRG-GU011, and NRG-HN010. These videos are posted on the NRG Oncology YouTube channel and also linked on the NRG Protocol table under “Documents and Materials” for the corresponding study. Additional videos from interviews held in Orlando will be coming soon.


Request for PILOT Project Applications

Date Issued: December 1, 2022

Submission Due Date: February 17, 2023

NRG Oncology NCORP solicits PILOT projects addressing NRG NCORP Health Disparities Research (HDR) priorities. PILOT projects should generate preliminary data and address feasibility issues to inform the development of a future NCORP concept. The current focus of HDC is to move past simply documenting outcome differences to the development and testing of interventions to remedy them. Applications for this award should address committee priorities including:

  • Focus 1. Development of interventional studies to decrease health disparities among disparity populations, including racial and ethnic minorities, residents in rural geographic areas, and individuals from other medically underserved groups.
  • Focus 2. Testing interventional studies for optimal care of at-risk elderly.
  • Focus 3. Identify optimal access to cancer screening, treatment, symptom management and surveillance among diverse disparity populations.


Please see full details located on the NRG Health Disparities Committee webpage.

PUBLICATIONS REMINDERS

 

Please note the following upcoming meeting and abstract submission deadline dates


UPCOMING MEETINGS

American Society of Clinical Oncology (ASCO) GU; Feb 16-18, 2023; San Francisco, CA


ESMO Gynaecological Cancers Annual Congress 2023; Feb 23-24, 2023; Barcelona, Spain


Society of Gynecologic Oncology (SGO); Mar 25-28, 2023; Tampa, FL


Society of Surgical Oncology (SSO) Feb 18-20, 2023; San Diego, CA Advanced Cancer Therapies (ACT)


Society of Surgical Oncology (SSO); March 22-25, 2023; Boston, MA


St. Gallen Breast Cancer Conference (SG-BCC); Mar 15-18, 2023; Vienna, Austria

 

UPCOMING ABSTRACT SUBMISSION DEADLINES

American Association of Physicists in Medicine (AAPM); July 23-27, 2023; Houston, TX; due to publications committee Feb 14, 2023; meeting submission deadline Feb 28, 2023 800 pm ET


American Society of Clinical Oncology (ASCO); Jun 2-6, 2023; Chicago, IL; due to publications committee Jan 24, 2023; meeting submission deadline Feb 14, 2023 1159 pm EST; LBA Mar 16, 2023 Noon (EST)


American Society for Radiation Oncology (ASTRO); Oct 1-4, 2023; Chicago, IL; due to publications committee Feb 9, 2023; meeting submission deadline Feb 13, 2023 1159 PT


ESMO Breast Cancer Annual Congress; May 11-13, 2023; Berlin, Germany; due to publications committee Feb 7, 2023; meeting submission deadline Feb 21, 2023 TiP, LBA placeholder 9 pm CET; LBA Apr 12, 2023 9pm CntEurSummrTime


ESMO World Congress on Gastrointestinal Cancer; Jun 28-Jul 1, 2023; Barcelona, Spain; due to publications committee Feb 27, 2023; meeting submission deadline Mar 13, 2023; LBA Jun 15, 2023


International Society for Quality-of-Life Research (ISOQOL); Oct 18-21, 2023; Calgary, AB Canada; due to publications committee Mar 20, 2023; meeting submission deadline Apr 3, 2023; LBA Jul 7, 2023

Facebook  Twitter  Instagram  LinkedIn